Cardiovascular magnetic resonance at 3-tesla (3T) has inherent technical challenges that are increasingly being overcome. Recently, some pacemakers and leads have been approved for 3T conditional use. The purpose of this report is to review B1+RMS, a new, more accurate parameter used to define energy deposition during magnetic resonance imaging, as well as to present the imaging protocol and procedure utilized to rule out causes of heart block in a patient with a pacemaker in-situ. This case demonstrates that high quality, diagnostic images can be obtained at 3T with conditional pacemakers in situ.
INTRODUCTION
Growth of cardiovascular magnetic resonance (CMR) has been paralleled by expanding indications and employment of cardiac implanted electronic devices (CIEDs). First-generation magnetic resonance imaging (MRI) conditional devices were limited to 1.5-tesla (1.5T) field strength. Recently, a small number of devices were designated "MRI conditional" status at 3-tesla (3T). Extra-thoracic MRI at 3T in patients with magnetic resonance (MR)-conditional CIEDs has been previously described [1, 2] . However, to our knowledge, no CMR of patients with CIED in-situ (i.e., directly within the field) at 3T have been reported in the literature. The purpose of this case study is to review B1+RMS [derived from the ten-second, time-averaged field strength or root mean square (RMS) of the flip angle (B1+)], a new parameter used to define energy deposition during MRI, as well as to present the imaging protocol and procedure utilized in a case of idiopathic, complete heart block.
Case RepORT
A 39-year-old male presented with a 5-day history of lethargy, dyspnea, coryzal symptoms, and no previous medical history. Electrocardiogram (ECG) demonstrated complete atrioventricular conduction block. Echocardiogram, biochemical, and haematologic investigations were normal. Informed consent was obtained.
Access to urgent CMR was limited, and insertion of an Ensura SureScan DR dual-chamber pacemaker with CapsureSense leads (Medtronic, Minneapolis, MN, USA) was performed (Fig. 1) . Pacing mode was DDD (dual-chamber, dual-sensing pacing with triggering and inhibiting functionality). CMR at six weeks was used to investigate secondary causes of heart block.
CMR protocol
Safety protocols were observed, and the pacemaker was switched to MR-conditional mode-DOO (dual-chamber paced, no sense, no response) at 80 beats-per-minute. Scanning was performed with the patient in a supine position, head first with MRI-safe ClearTrace 2 electrodes (CONMED, Utica, NY, USA) for ECG capture. A MAGNETOM Skyra 3T MRI and PERU monitoring device (Siemens, Erlangen, Germany) were used for cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/bync/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Cardiology, Gold Coast University Hospital, Southport, Queensland, Australia weighted, fat saturated, first-pass perfusion, and late gadoliniumenhanced (LGE) sequences were obtained ( Fig. 2A-C) . The predicted specific absorption rate (SAR) was <1.7 W/kg for each sequence. All sequences fell well below the 2.8 μT B1+RMS threshold.
CVIA

Case findings
CMR did not demonstrate myocardial oedema or pathological late-gadolinium enhancement. Ventricular size and function were normal. Minimal CIED-related artifacts occurred, and high-quality images were obtained with excellent ventricular blood-to-myocardial contrast ratio (BMCR) and contrast-tonoise ratio (CNR) [3] for the short-axis cine (BMCR 2.64; CNR 23.75) and LGE (BCMR 24.93; CNR 29.84) sequences.
The patient remained asymptomatic throughout the study. Subsequent interrogations confirmed that CIED parameters were unchanged post-MRI, and that the patient was pacemaker dependent, supporting the diagnosis of idiopathic complete heart block.
DIsCUssION
CMR did not demonstrate evidence of myocarditis or infil-CMR acquisitions: gradient-recalled echo cine sequences were substituted for balanced steady-state free precession series to reduce the B1+RMS and CIED-related artifact. T1-weighted, T2- Fig. 2 . A 39-year-old male with idiopathic, third degree atrioventricular-conduction block. Cardiovascular magnetic resonance (A) T2 fat-saturated sequence demonstrated no myocardial oedema (white arrow), (B) 4-chamber and 2-chamber gradient-recalled echo cine sequences demonstrate normal structure and function with excellent spatial resolution, minimal artefact related to pacemaker leads (white arrowheads), (C) short axis first-pass perfusion and late gadolinium-enhanced sequences excluded resting perfusion deficits and myocardial scar (white arrows), and (D) B1+RMS prediction displayed in the specific absorption rate Monitor Operating Mode window of a Siemens Skyra MRI system. CVIA trative myocardial disease as a cause for heart block. This case highlights the efficacy and safety of CMR at 3T to investigate causes of heart block in patients with an MR conditional pacemaker in situ.
Potential safety concerns exist when imaging patients with CIEDs. These include induced currents, heating, torque, and antenna effects related to radio-frequency (RF) energy deposition.
specific absorption rate
SAR is the traditional metric for calculating RF power absorbed per unit of mass. It varies between patients and cannot be directly measured during MRI acquisitions. SAR has no universal standard, varies between MRI systems, and is a poor predictor of implant temperature changes. Thus, its use to guide safe imaging is unreliable and potentially dangerous [4] .
B 1+RMs
B1+RMS is a parameter available on 3T MRI scanners built after 2013. It provides more accurate indications of energy absorption than SAR with in-situ CIEDs and is independent of patient factors. Adjusting parameters to reduce SAR also typically reduces B1+RMS; examples are listed in Table 1 [5] .
Energy deposition thresholds vary between manufacturers, as will the location of the B1+RMS display on scanner consoles (Fig. 2D) . SureScan CIEDs have a maximum B1+RMS threshold of 2.8 μT for thoracic imaging at 3T.
summary
This case demonstrates that high-quality diagnostic images can be obtained safely in patients with MR conditional CIEDs in situ at 3T field strength (traditionally limited to 1.5T). Strict adherence to safety protocols and vendor MR conditions is required. 
